서비스분야
현재 위치：홈 > Services & Solutions
Our CMC department focuses on establishing large-scale synthetic routes along with formulation development and quality control. Our drug categories can be proprietary drugs or generic drugs. All studies are complied with ICH and CFDA guidelines.
Medicilon’s packaging can provide single window and double blind clinical trial material labeling options. We can also provide different types of line with current GMP standard clinical production of packaging services based on customer requirements.
Medicilon is a leading provider of comprehensive, high quality recombinant protein and bioprocess services. We offer a variety of recombinant protein expression platforms along with a host of other protein services like chemical protein synthesis, protein refolding and structural biology services.
Medicilon established a well-developed structural biology research platform. Medicilon is proud as the one firstly provides gene to crystal structure service in China. Medicilon has well-established integrated service platform, which has been certified as an important platform for drug discovery by Shanghai Government.
Our Discovery Biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.
Medicilon offers prepackaged M9 selenomethionine (SeMET) growth media kits and packages for growing cell culture in IPTG-inducible bacterial expression systems, leading to the production of SeMET-labeled proteins for crystallographic studies using MAD.
Medicilon's team integrates expertise in Kinase Services with deep knowledge of regulatory, market access and commercial global pathways. This service was designed to meet your specific needs fast at extremely competitive prices. We can also provide screening services on specified signaling pathways areas in accordance to your needs.
Our structural biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.
